Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marcel Spulak is active.

Publication


Featured researches published by Marcel Spulak.


Green Chemistry | 2012

Antimicrobial toxicity studies of ionic liquids leading to a ‘hit’ MRSA selective antibacterial imidazolium salt

Deborah Coleman; Marcel Spulak; M. Teresa Garcia; Nicholas Gathergood

Imidazolium salts can be classed as surfactants, detergents, ionic liquids, reagents, catalysts or solvents. A study of the toxicity and ecotoxicity of these salts yields valuable information for their use as pharmaceuticals as well as impact on the environment. Our approach to screen a series of chiral imidazolium salts for toxicity to bacteria and fungi, including clinical pathogen strains, has led to the identification of a ‘hit’ MRSA selective antimicrobial compound. Preliminary structure–activity-relationship (SAR) information (required position of L-phenylalanine and L-valine group) is also elucidated within this first generation of compounds. Conversely, most of the imidazolium salts were nontoxic (IC95 > 2 mM) to the 12 fungi strains and 8 bacteria strains screened, and we propose that they are suitable candidates for ‘green chemistry’ applications. Ecotoxicity studies (Biodegradation ISO 14593 ‘CO2 Headspace Test’) of two bromide ionic liquids containing L-phenylalanine residues indicate that these ionic liquids passed the test (>60% in 28 days) and classed as readily biodegradable.


Bioorganic & Medicinal Chemistry | 2003

Synthesis and structure–antifungal activity Relationships of 3-Aryl-5-alkyl-2,5-dihydrofuran-2-ones and Their Carbanalogues: further refinement of tentative pharmacophore group

Milan Pour; Marcel Spulak; Vojtěch Balšánek; Jiří Kuneš; Petra Kubanová; Vladimír Buchta

Two series of 3-(substituted phenyl)-5-alkyl-2,5-dihydrofuran-2-ones related to a natural product, (-)incrustoporine, were synthesized and their in vitro antifungal activity evaluated. The compounds with halogen substituents on the phenyl ring exhibited selective antifungal activity against the filamentous strains of Absidia corymbifera and Aspergillus fumigatus. On the other hand, the influence of the length of the alkyl chain at C(5) was marginal. The antifungal effect of the most active compound against the above strains was higher than that of ketoconazole, and close to that of amphotericin B. In order to verify the hypothesis about a possible relationship between the Michael-accepting ability of the compounds and their antifungal activity, a series of simple carbanalogues, 2-(substituted phenyl)cyclopent-2-enones, was prepared and subjected to antifungal activity assay as well.


Green Chemistry | 2010

Highly recyclable, imidazolium derived ionic liquids of low antimicrobial and antifungal toxicity: A new strategy for acid catalysis

Lauren Myles; Rohitkumar G. Gore; Marcel Spulak; Nicholas Gathergood; Stephen J. Connon

Imidazolium derived ionic liquid catalysts have been developed which are aprotic and of low antimicrobial and antifungal toxicity, yet which can act as efficient Bronsted acidic catalysts in the presence of protic additives. The catalysts can be utilised at low loadings and can be recycled 15 times without any discernible loss of activity.


Bioorganic & Medicinal Chemistry Letters | 2000

3-Phenyl-5-methyl-2H,5H-furan-2-ones: tuning antifungal activity by varying substituents on the phenyl ring.

Milan Pour; Marcel Spulak; Vojtech Balsanek; Jiri Kunes; Vladimír Buchta; Karel Waisser

A series of racemic 3-phenyl-5-methyl-2H,5H-furan-2-ones related to a natural product, (-)incrustoporine, was synthesized, and their antifungal activity evaluated. The key structural feature, furanone ring, was closed via H2SO4-mediated cyclization of 2-phenylpent-4-enoic acids. The compounds displayed antifungal activity, especially against filamentous fungi. Expressed as the minimum inhibition concentration (MIC) in micromol/L, the activity of the most promising derivative against Absidia corymbifera matched that of ketoconazole (31.25 micromol/L). In terms of microg/mL, the substance was more active (7.6 microg/mL) than this standard antifungal drug (16.6 microg/mL).


Journal of Organic Chemistry | 2010

Direct C−H Arylation and Alkenylation of 1-Substituted Tetrazoles: Phosphine As Stabilizing Factor

Marcel Spulak; Richard Lubojacký; Petr Šenel; Jiří Kuneš; Milan Pour

Direct arylation and alkenylation of 1-substituted tetrazoles was achieved via Pd catalysis in the presence of CuI and Cs(2)CO(3). Unlike the related reactions of imidazoles and purines, phosphine ligand was necessary to prevent the intermediate tetrazolyl-Pd(II) species from fragmentation into the corresponding cyanamide. Various 1,5-disubstituted tetrazoles were prepared with good to excellent isolated yields.


Green Chemistry | 2013

A new generation of aprotic yet Brønsted acidic imidazolium salts: effect of ester/amide groups in the C-2, C-4 and C-5 on antimicrobial toxicity and biodegradation

Rohitkumar G. Gore; Lauren Myles; Marcel Spulak; Ian Beadham; T. García; Stephen J. Connon; Nicholas Gathergood

Imidazolium Bronsted acidic catalysts substituted with ester/amides have been assessed for both antimicrobial toxicity and biodegradation. Low toxicity to a screen of 20 microbial strains (12 fungi and 8 bacteria) was demonstrated. Imidazolium salts incorporating either ester or amide groups at N-1, C-2, C-4 and C-5 did not pass the readily biodegradable test (ISO 14593). Catalyst selection based on Traffic Signal Light classification of performance, (eco)toxicity, and efficient synthesis is described.


Green Chemistry | 2014

Low toxicity functionalised imidazolium salts for task specific ionic liquid electrolytes in dye-sensitised solar cells: a step towards less hazardous energy production

Mukund Ghavre; Owen Byrne; Lena Altes; Praveen K. Surolia; Marcel Spulak; Brid Quilty; K. Ravindranathan Thampi; Nicholas Gathergood

Novel solvent free task specific ionic liquid (TSIL) electrolytes for dye sensitised solar cells (DSSC) were synthesised and tested. Of great concern is the replacement of low-moderate toxicity second generation ILs, with high toxicity third generation TSILs. As most 1-butyl-3-methylimidazolium (Bmim) and especially 1-ethyl-3-methylimidazolium (Emim) based ILs have low toxicity, the designing of replacement TSILs of comparable toxicity is a challenge. Structural features of TSIL investigated herein were incorporation of heteroatoms into the side chain of imidazolium cations (i.e. ether, ester and amide) and anion (bromide, iodide, and triflimide [NTf2]). Preliminary toxicity screening against 20 microorganisms (8 bacteria and 12 fungi) found that all ILs, imidazolium salts, N-butylbenzimidazole (NBB) and guanidinium thiocyanate (GNCS) do not exhibit high antimicrobial toxicity. However NBB and a pentyl ester substituted IL displayed moderate toxicity to several strains of bacteria and fungi. Further toxicity testing to establish IC50 values shows several novel TSIL compounds and imidazolium salts are in fact less toxic to microorganisms (e.g. bacteria) than commonly used 1-ethyl-3-methylimidazolium iodide (EmimI) and 1,3-dimethylimidazolium iodide (DmimI). We have demonstrated that the presence of ether and either ester or amide groups in the structure of the cation of the TSIL and imidazolium salts reduces antimicrobial toxicity, which is consistent with the lowering of the lipophilicity of ILs. Iodide and bromide analogues have lower toxicity than the NTf2 examples in this study. The DSSC performance using these “greener” ILs in place of the standard EmimI compare quite favourably. Two low antibacterial toxicity iodide examples exhibit photocurrents of 9.27 mA cm−2 and 8.85 mA cm−2, respectively, achieving promising efficiencies of 3.39% and 3.31%, respectively (EmimI = 4.94%). DSSC performance is further improved by 15% minimum to 66% maximum, depending on IL chosen, by the presence of small amounts of moisture and DSSCs employing a low antibacterial toxicity iodide TSIL or imidazolium salt can surpass the performance of dry EmimI. Of note the DSSC containing TSIL NTf2 examples, performed poorly compared to the halide analogues, with the outcome that the most toxic TSILs under investigation are also the least preferred based on performance.


Analytical and Bioanalytical Chemistry | 2013

Investigation of the metabolism of monepantel in ovine hepatocytes by UHPLC/MS/MS

Lucie Stuchlíková; Robert Jirásko; Ivan Vokřál; Jiří Lamka; Marcel Spulak; Michal Holčapek; Barbora Szotáková; Hana Bártíková; Milan Pour; Lenka Skálová

Monepantel (MOP) belongs to a new class of anthelmintic drugs known as aminoacetonitrile derivatives. It was approved for use in veterinary practice in Czech Republic in 2011. So far, biotransformation and transport of MOP in target animals have been studied insufficiently, although the study of metabolic pathways of anthelmintics is very important for the efficacy of safety of therapy and evaluation of the risk of drug–drug interactions. The aim of this study was to identify MOP metabolites and to suggest the metabolic pathways of MOP in sheep. For this purpose, primary culture of ovine hepatocytes was used as a model in vitro system. After incubation, medium samples and homogenates of hepatocytes were extracted separately using solid-phase extraction. Analysis was performed using a hybrid quadrupole-time-of-flight analyzer with respect to high mass accuracy measurements in full scan and tandem mass spectra for the confirmation of an elemental composition. The obtained results revealed S-oxidation to sulfoxide and sulfone and arene hydroxylation as MOP phase I biotransformations. From phase II metabolites, MOP glucuronides, sulfates, and acetylcysteine conjugates were found. Based on the obtained results, a scheme of the metabolic pathway of MOP in sheep has been proposed.


Green Chemistry | 2016

Synthesis of a series of amino acid derived ionic liquids and tertiary amines: green chemistry metrics including microbial toxicity and preliminary biodegradation data analysis

Andrew Jordan; Annette Haiß; Marcel Spulak; Yevgen Karpichev; Klaus Kümmerer; Nicholas Gathergood

A series of L-phenylalanine ionic liquids (ILs), L-tyrosine ILs, tertiary amino analogues and proposed transformation products (PTPs) have been synthesised. Antimicrobial toxicity data, as part of the green chemistry metrics evaluation and to supplement preliminary biodegradation studies, was determined for ILs, tertiary amino analogues and PTPs. Good to very good overall yields (76 to 87%) for the synthesis of 6 ILs from L-phenylalanine were achieved. A C2-symmetric IL was prepared from TMS-imidazole in a one-pot two-step method in excellent yield (91%). Synthesis of the L-tyrosine IL derivatives utilised a simple protection group strategy by using an extra equivalent of the bromoacetyl bromide reagent. Improvements in the synthesis of the α-bromoamide alkylating reagent from L-phenylalanine were achieved, directed by green chemistry metric analysis. A solvent switch from dichloromethane to THF is described, however the yield was 15% lower. Antimicrobial activity testing of L-phenylalanine ILs, L-tyrosine ILs, tertiary amino analogues and PTPs, against 8 bacteria and 12 fungi strains, showed that no compound had a high antimicrobial activity, apart from an L-proline analogue. In this exceptional case, the highest toxicity (IC95 = 125 and 250 μM) was observed towards the two Gram positive strains Staphylococcus aureus and Staphylococcus epidermidis respectively. High antimicrobial activity was not found for the other bacteria or fungi strains screened. The limitations of the antimicrobial activity study is discussed in relation to SAR studies. Preliminary analysis of biodegradation data (Closed Bottle Test, OECD 301D) is presented. The pyridinium IL derivative is the preferred green IL of the series based on synthesis, toxicity and biodegradation considerations. This work is a joint study with Kummerer and co-workers and the PTPs were selected as target compounds based on concurrent biodegradation studies by the Kummerer group. For the comprehensive biodegradation and transformation product analysis see the accompanying paper.


Bioorganic & Medicinal Chemistry | 2010

Antifungal 3,5-disubstituted furanones: From 5-acyloxymethyl to 5-alkylidene derivatives

Petr Šenel; Lucie Tichotova; Ivan Votruba; Vladimír Buchta; Marcel Spulak; Jiří Kuneš; Milan Nobilis; Ondřej Krenk; Milan Pour

5-Acetoxymethyl-3-(4-bromophenyl)-2,5-dihydrofuran-2-one previously described as highly antifungally active was found to provide the corresponding 5-methylene derivative via an unusual DMSO-promoted elimination of the ester group at C5 under antifungal assay conditions. Since the latter possessed nearly the same antifungal effect as that originally reported for the former, the 5-acetoxymethyl furanone just served as a precursor of the actual antifungally active species. A few series of compounds with alkyloxy, aryloxy and alkylidene substituents at C5 of the parent furanone structure were therefore prepared and evaluated. In line with the ease of elimination of the substituent from C5, low activities of the 5-alkoxy compounds were observed. On the other hand, their 5-aryloxymethyl congeners were found to be capable of liberating the antifungally active 5-methylene furanone into the testing medium. The antifungal effect of the 5-alkylidene derivatives was highly sensitive to substitution of the alkylidene moiety; a substituent in the allylic position was necessary for a compound to retain high activity. Parallel evaluation of cytostatic activity showed moderate activities of the antifungally active derivatives against HeLa S3 and CCRF-CEM lines. Cell cycle analysis of CCRF-CEM cells following the treatment with 5-methylene-3-(4-bromophenyl)-2,5-dihydrofuran-2-one revealed that this compound is a necrotic agent.

Collaboration


Dive into the Marcel Spulak's collaboration.

Top Co-Authors

Avatar

Milan Pour

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jiří Kuneš

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Vladimír Buchta

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Nicholas Gathergood

Tallinn University of Technology

View shared research outputs
Top Co-Authors

Avatar

Ivan Votruba

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Jiri Kunes

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Lucie Tichotova

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Nicholas Gathergood

Tallinn University of Technology

View shared research outputs
Top Co-Authors

Avatar

Brid Quilty

Dublin City University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge